Links between gut bacteria, brain chemicals, and mental health problems

The human microbiota consists of numerous species and plays an essential role in several functions, including the digestive process, vitamin synthesis, and metabolism.^[1,2] A balanced microbiota population is crucial for homeostasis,^[3] Therefore, the abnormal composition of human microbiota may lead to several illnesses like immune system issues, infections, and neuropsychiatric disorders.^[1,4] The greatest number and diversity of these microorganisms are found in the gut.^[5] Recently, a growing body of evidence suggests that gut microbiota including bacteria, eukaryotes, and archaea has a significant role in the pathophysiology of several illnesses in many systems and organs.^[3,6] The brain is one of the organs that is affected by the gut microbiota through the gut-brain axis.^[3,5]

The gut-brain axis is a complex communication system connecting the gut with the brain, which works through a combination of neural, immunological and chemical signaling pathways, comprising the vagus nerve as one of the most important direct pathways. The immune system is also impacted by both the gut and the brain, with the gut microbiota playing a critical role in immune system physiology.^[7] Additionally, chemical substances, such as short-chain fatty acids (SCFAs) and neurotransmitters produced by the gut microbiota directly influence brain function.^[4]

The gut-brain axis is found to be implicated in the pathophysiology of numerous mental health disorders, such as depression, anxiety and many more.^[8] Several studies on mice have shown that the gut microbiota and their byproducts can influence behavior in cases of autism spectrum disorder (ASD).^[9] In this article, we will review in more detail some of these disorders and their correlation with gut microbiota.

Understanding how the gut-brain axis works has led to the development of novel therapeutic approaches aimed at targeting the gut microbiota to improve brain disorders symptoms. Microbiome-based therapeutic interventions, including probiotics, prebiotics, fecal microbiota transplant (FMT) and dietary interventions have all been explored as potential strategies aimed to support mental well-being.^[10] Kang et al showed significant improvements regarding both gastrointestinal (GI) and behavioral symptoms in children with ASD, that were still detectable 2 years after discontinuing the microbiota transfer therapy treatment.^[9] Unravelling the intricacies of this complex dynamic system might help researchers develop novel treatments for a wide range of conditions that involve disturbances in gut-brain communication.^[4]

Eubiosis refers to the state of equilibrium in the formulation and composition of the gut microbiome. Gut microbes are essential for the maintenance of the intestinal microenvironment, gut barrier homeostasis, motility, and immune system regulation.^[11] Gut dysbiosis is, therefore, defined as an alteration or disruption in the balance, composition and diversity of the gut microbiome. This imbalance can involve an abundance in the pathobionts (pro-inflammatory cytokines producing microbes), in opposition to a scarcity of the symbionts (anti-inflammatory cytokines producing microbes). Several mechanisms are integrated in the pathophysiology of gut dysbiosis, comprising an increased permeability due to decreased expression of claudin-5 and occludin (tight junction proteins linking between intestinal epithelial cells), all of which ultimately results in what is known as the leaky gut syndrome.^[12] Leaky gut syndrome can precipitate systemic inflammation by making it easier for the gut bacteria to enter the bloodstream.^[11] Another pathophysiological mechanism, in which leaky got syndrome can evoke systemic inflammation, is by disintegrating the blood-brain barrier through impairing the junction proteins in the hippocampus, striatum and frontal lobe cortex. These alterations in the brain permeability prompt a faulty displacement and increased immigration of immune cells, as well as harmful microbial metabolites toward the brain, which can consequently elevate cytokines and endocrinal stress transmitters in the brain tissue.^[12] As a result, gut dysbiosis is related to unpleasant health conditions, including diabetes, obesity and asthma, in addition to a wide variety of diseases affecting the GI, cardiovascular and central nervous system (CNS).^[11,12] The close linkage between gut dysbiosis and neuropsychiatric disorders has recently become more evident with forthcoming clinical research highlighting the coexistence of dysfunctional GI tract in patients with depression, autistic disorder, anxiety and schizophrenia.^[11,12] More research is still, however, required to identify the exact pathophysiology behind the route of influence in between gut dysbiosis and brain disorders.

Based on the clear relationship between gut microbiota and the brain, we discuss in this review the role of gut microbiota in both neurotransmitters and mental disorders. We chose 4 neurotransmitters [tryptophan and serotonergic system, dopamine, gamma-aminobutyric acid (GABA), and glutamate] and 4 psychiatric illnesses (schizophrenia, depression, anxiety disorders, and ASD) (Fig. 1). These widespread disorders have a great impact on public health especially in low-income countries.

Tryptophan is an essential alpha-amino acid acquired almost exclusively from a protein-rich diet.^[13,14] The World Health Organization advises that a total of 4 mg/kg of tryptophan is achieved daily.^[15] Tryptophan has the chemical formula: 2-amino-3 (1H-indol-3-yl) propanoic acid and can exist in 3 different isomeric arrangements (D, L, DL).^[13,14] In addition to its key role in numerous physiological processes including protein synthesis,^[13] maturation and regulation of immunological and neuropsychological functions,^[16] and maintaining homeostasis of the gut environment,^[4] tryptophan is also the precursor to many bioactive metabolites which physiologically influence the human body and sustain its homeostasis.^[13] Due to the extensive surface area of the human GI tract, a complex diverse ecosystem of approximately 100 trillion microorganisms from 1000 to 5000 various species, termed the gut microbiota, colonize the surface of the gut wall in the alimentary canal.^[7,15,16] The gut microbiota affects the metabolism of host tryptophan in multiple direct and indirect mechanisms; the direct methods are executed by metabolites of the resident bacteria, including SCFAs, indole derivatives, and hydrogen peroxide; indirect methods comprise immunological modulations influencing the tryptophan metabolism pathway.^[17] Upon digestion, dietary tryptophan is released in the small intestine, where it can be absorbed into the peripheral bloodstream to serve as a metabolic substrate to the host cells,^[14,17] be transformed into serotonin by the enterochromaffin cells, or degraded via the kynurenine pathway.^[14] The minority of unabsorbed tryptophan is processed by the gut microbiome into biomolecule derivatives called indoles, which are essential for maintaining the communication and survival of the resident bacteria.^[14,17] Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine metabolite that is derived from tryptophan in a conversion mediated by tryptophan hydroxylase.^[17,18] It plays a crucial role as a neurotransmitter that regulates mood, body temperature, pain perception, food intake and appetite, circadian rhythm, sexuality, memory, and stress response.^[18,19] Numerous bacterial species, including Streptococcus, Lactobacillus, Klebsiella, and Escherichia coli have reportedly expressed serotonin-synthesizing properties via tryptophan synthetase mediation.^[18] Since 90% of serotonin synthesis occurs peripherally in the distal GI tract, it is of no surprise that forthcoming research is linking tryptophan metabolism, and serotonin host levels to the gut microbiota.^[14]

Evidence on the effect of the gut microbiome on tryptophan metabolism is established by research on animal models depleted of gut microorganisms.^[14] Studies on germ-free mice revealed an increase in plasma tryptophan and brain serotonin concentration, that shifted back to normal after gut microbiota is established post-weaning, which is an expected finding since these commensal microorganisms utilize tryptophan as a metabolic substrate.^[14,17] Findings from studies on animal models concluded that host tryptophan availability could be limited by manipulation of the microbiome and subsequently tryptophan metabolic pathways.^[18] The accommodating bacteria effect on brain functions via the gut serotonin system was recognized in a study that found that spore-forming bacteria could directly stimulate serotonin biosynthesis via a complex metabolite/cell component-sustained mechanism in the enterochromaffin cells inside the mice and human GI tract.^[17,18]

Normal host microbiome plays a protective buffer to the serotonergic system against fluctuations of its tryptophan-derived precursors, however, a study on germ-free mice exhibited that alterations in the serotonergic system could not be normalized by reinstating the microbiological ecosystem in early adolescence, suggesting that gut microbes can only execute their effects on the serotonergic system during a developmental window. Correspondingly, host serotonin fluctuations influence the gut microenvironment, because serotonin is a signaling molecule that enhances bacterial growth in specific colonies.^[17]

It has also become clear that tryptophan and serotonin are centrally integrated in the pathogenesis of many neurological and psychiatric disorders, such as depression and anxiety.^[14] Hence, experiments on germ-free mice displayed relatively more anxious behavior in comparison with the control group of conventionally-raised mice, which probably suggest a humoral pathway through which, the microbiota could alter serotonergic neurotransmission in the brain.^[14,18] Moreover, multiple studies investigated the impact of 5-HT modulation on depression and/or anxiety using microbiome-dependent interventions.^[20]

Additionally, Tryptophan metabolism is, to a wide extent, involved with depression; results of a study regarding tryptophan influence on affective disorders revealed improvement in mood states and a decline in depressive symptoms in individuals following a tryptophan-rich diet, in comparison with anxiety and irritability in counterparts on a low-tryptophan diet.^[19] Kelly et al studied the effect of gut microbes on altering kynurenine metabolism and consequently depressive features by applying FMT from depressed patients into microbiome-devoid rats; they reported depressive manners accompanied by substantial kynurenine to tryptophan ratio increase in the plasma.^[21] Higher susceptibility to schizophrenia and suicidal behavior is linked to specific polymorphisms in the tryptophan hydroxylase1 enzyme, plausibly due to an impairment in the tryptophan to serotonin conversion pathway. Furthermore, low levels of the serotonin metabolite: 5-hydroxyindole acetic acid in the cerebrospinal fluid were associated with suicidal and aggressive behavior.^[14]

Understanding the precise ways gut microbiota and tryptophan metabolism crosstalk in the pathophysiology of depression might open new horizons toward more efficient treatments for this disorder, which affects over 240 million people globally.^[15]

Dopamine is a neurotransmitter generated in both the CNS and the periphery and acts by attaching to G protein-coupled receptors.^[22] Dopamine is delivered to the brain via the phenylalanine-tyrosine-dopa-dopamine route. The rate-limiting enzyme in this process is tyrosine hydroxylase, which hydroxylates tyrosine and produces levodopa (L-dopa) using tetrahydrobiopterin as a cofactor.^[23] Dopamine has a broad range of activities. It is essential for excitement, mobility, mood, and the execution of activities that involve fast decisions and learning through reward.^[24] There is a strong relationship between the gut microbiome and dopamine. Some gut microorganisms have been found to have neuroprotective effects on dopaminergic neurons, slowing dopamine depletion. Other bacteria, on the other hand, can have a detrimental impact by activating inflammatory responses via endotoxins, further depleting dopamine quantities.^[25]Lactobacillus casei (L casei), for example, can increase the levels of monoamines dopamine, 5-HT, and norepinephrine in the frontal brain of rats.^[26]Prevotella, Bacteroides, Lactobacillus, Bifidobacterium, Clostridium, Enterococcus, and Ruminococcus have roles in regulating receptors, transporters, and particular targets of the dopaminergic pathway either positively or negatively. Several investigations have shown that L-dopa supplementation allows Enterococcus faecium in the GI tract to convert L-dopa into dopamine. Furthermore, neuroimaging revealed that transplanting both Enterococcus faecalis and E faecium into a mouse model of Parkinson disease significantly increased the amount of striatal dopamine.^[25] Dopamine also affects pathogenic bacteria, such as E coli, which grows faster in the presence of dopamine and norepinephrine.^[27] In light of these facts, many interventions can be done to modify dopamine levels by affecting gut microbiota leading to several therapeutic applications on diseases caused by disruption of the healthy gut microbiota, including Parkinson disease, attention deficit hyperactivity disorder, depression, anxiety disorder and ASD.^[25]L casei intervention can ameliorate the changes in intestinal microbiota composition caused by chronic unpredictable mild stress (CUMS), indicating that L casei supplementation could improve dysbacteriosis caused by depression and restore the homeostasis of intestinal microbiome microecology.^[26] Taking Lactobacillus plantarum for 12 weeks decreased stress and anxiety in stressed individuals compared to a placebo group, and this was associated with alterations along the brain neurotransmitter pathways of serotonin and dopamine-norepinephrine.^[28] Recent genomic investigations have discovered that ephrin B6 (EPHB6) is altered in some ASD patients. EPHB6 is a potential ASD-associated gene and is a member of the ephrin family of receptor tyrosine kinases. A study using EPHB6-deficient animals revealed a new regulatory function for the gut microbiota on dopamine in the prefrontal cortex by affecting vitamin B6 levels. The study findings suggested that deficiencies in vitamin B6 reduced dopamine levels, which in turn caused social deficits and an excitation/inhibition imbalance in mice lacking the enzyme ephB6.^[29] According to another study, the unique alkaloid neferine, which is derived from the seed of the lotus plant, has therapeutic effects on depressed mice because it can diminish hippocampal nerve damage, reduce anti-depressant neurotransmitter secretion, and improve the structure of the gut microbiota. Particularly, Lactobacillus may be the gut microbial target of neferine in alleviating the symptoms of depression.^[30] The consumption of Bacillus coagulans can lessen the anxiety- and depression-like phenotypes caused by CUMS and maternal separation models in rats. The alteration of the gut-brain axis’ microbiome may be responsible for the reversal of emotional behavior after treatment with B coagulans.^[31]

GABA is an inhibitory neurotransmitter which plays an important role in behavior, cognition, and the body response to stress, it has also been associated with several positive health effects, such as reducing anxiety and menopausal syndrome symptoms, boosting immunity, treating depression and insomnia, regulating blood pressure, fighting obesity, improving the visual cortex performance.^[32]

The postsynaptic membrane has 3 GABA receptors (GABARs) called alpha, beta, and gamma that can recognize and bind GABA. When GABA binds to GABARs in humans, it opens ion channels at the inhibitory synapses, allowing chloride ions to enter the cell and potassium ions to exit.^[33] Glutamate decarboxylase catalyzes the α-decarboxylation of l-glutamate to produce GABA.^[34] Currently, there are numerous methods for obtaining GABA, including chemical synthesis, enriching plants, enzymatic processes, and microbial production.^[35] GABA can also be produced from ornithine, arginine, and putrescine, and numerous human gut bacteria have been found to contain homologous biosynthesis enzymes.^[36]

Bacteria use neurotransmitters to communicate with the CNS and release molecules into the bloodstream that regulate physiological processes in the intestinal wall.^[37] The Parabacteroides and Eubacterium genera were identified as GABA producers,^[38] along with Lactobacillus, Bifidobacterium, Bacteroides,^[37] and Blautia,^[39] specifically Bacteroides fragilis.^[37]

A recent human study showed that transplantation of the fecal microbiota from lean to obese people increased plasma GABA levels.^[38] And it also increased in the hippocampus and prefrontal cortex after treatment with Lactobacillus.^[37] Reduced levels of Bifidobacterium pseudolongum and elevated levels of Desulfovibrio piger and Mucispirillum schaedleri may be able to decrease hippocampal GABA levels.^[40]

According to human studies to date, the gut microbiome is altered in major depression.^[41] The expression of GABARs was changed in the brain by Lactobacillus rhamnosus, which decreased depression and anxiety.^[37] One of the products of Blautia-dependent arginine metabolism is the gut microbial neurotransmitter GABA, its increase was linked to a lower risk of Alzheimer Disease.^[39] Due to its inverse relationship with GABA levels, the abundance of M schaedleri may be associated with the development of postpartum depression.^[40] Given that AD develops over a long prodromal period, it is conceivable that early interventions targeting the microbiota could be effective in treating this disorder in the future (e.g., antibiotics, psychobiotics, or gut microbiota transplantation).^[39]

Glutamate is a non-essential amino acid that is found in a wide variety of foods and natural substances including meat, fish, cheese, and vegetables.^[42,43] Other endogenous sources include the body production of glutamate from metabolic pathways or its release from synaptic vesicles. It is also stored in nerve cells for later use.^[44] Glutamate metabolic pathway is a complex biochemical process that comprises 89 metabolites, most importantly: N-acetyl-l-glutamate, δ-1-pyrroline-5-carboxylate, β-citrylglutamate, l-γ-glutamyl-l-cysteine. Glutamate is synthesized from glutamine, α-ketoglutarate, and 5-oxoproline.^[45] It is a crucial factor in taste perception and signal transmission in the brain. Glutamate is also the major excitatory neurotransmitter and the most concentrated amino acid in the CNS. Conversely, the major inhibitory neurotransmitter, GABA, is synthesized from glutamate.^[42,46] Enteric glutamate contributes significantly to the microbiota-gut-brain axis.^[47] Various molecules produced by gut microbiota may regulate diverse functions in the intestinal tract, such as metabolic, nutritional, and immune responses. Additionally, they can impact brain activity, leading to a microbiome-driven control of the CNS. In this scenario and because glutamate plays a role in regulating various functions along the gut-brain axis, conditions such as depression,^[48] Alzheimer disease, ASD,^[42] and other neuropsychological disorders are linked with glutamatergic signaling and the makeup of the gut microbiota.^[46] Multiple studies have shown that changes in gut microbiota can alter brain levels of glutamate.^[46] These findings suggest that the gut microbiota may affect glutamate production in the brain through enzymatic pathways and l-tryptophan metabolism is an indirect pathway through which the gut microbiota can influence glutamate pathways. Furthermore, prospective animal studies showed that microorganisms in the intestines can regulate the metabolism of d-amino acids in the brain, this finding was further supported by research on autism patients.^[42,46] Moreover, it has been hypothesized that plasma and fecal levels of glutamate are influenced by the compilation of the gut microbiota. Animal studies indicate that the gut microbiota can alter the ratios of hippocampal GABA/glutamate levels, which are critical for synaptic plasticity, learning, and memory mechanisms.^[42] Additionally, there is evidence linking changes in the gut microbiome with GI disorders such as irritable bowel syndrome and inflammatory bowel disease. In these conditions, alterations in glutamate signaling may also contribute to symptom development.^[46]

Schizophrenia is a principal cause of impairment globally, with a lifetime prevalence of 1% and a highly heterogeneous etiology.^[49–51] The gut microbiome has been linked to the development and maintenance of schizophrenia,^[52] This association has been a prominent trend in schizophrenia research for the past 50 years,^[53] primarily due to advances in sequencing methods.^[54] A recent systematic review revealed that schizophrenia often exhibits higher levels of Prevotella and lower levels of Haemophilus, Bacteroides, and Streptococcus.^[55] These gut microbes could be involved in the pathogenesis of schizophrenia by causing or exacerbating neuroinflammation due to gut dysbiosis. This could happen in multiple ways, including microbial translocation to the systemic circulation, enhanced release of cytokines, and via the vagus nerve through the cholinergic anti-inflammatory pathway.^[49,56] The interaction of stress and dysregulation of the gut microbiome is also important. Gut dysbiosis may increase stress sensitivity through the hypothalamic-pituitary-adrenal (HPA), a major neuroendocrine unit that regulates mood. Furthermore, stressful life events combined with the effects of the gut-brain axis may incite bidirectional complications leading to or exacerbating schizophrenia.^[49,51,57] The role of GABAergic transmission in schizophrenia has recently risen in significance, while gut commensal strains Lactobacillus and Bifidobacterium have been found able to produce GABA.^[58] Some GI hormones have been linked to cognition. The gut microbiome influences the secretion of these hormones, modifying the ecology and function of the gut microbiome.^[59] Several studies have linked specific clinical features of schizophrenia to unique gut microbial states, but the correlations from each study have not been consistently replicated.^[60] Manipulating the gut microbiome may modify the metabolism of d-amino acids, one of which is d-serine, a non-essential amino acid with antipsychotic activity and a selective full agonist of N-methyl-d-aspartate-type glutamate receptor. Decreased levels of d-serine could be associated with schizophrenia, as N-methyl-d-aspartate receptor antagonists have recently been associated with cognitive impairments.^[58,61] There has been significant data suggesting that the gut microbiome composition is responsible for a drug-unresponsive form of psychosis, an effect that could be alleviated with parenteral drug administration.^[62] Further, several studies described specific alterations in the gut microbiome composition, which co-occurred with metabolic comorbidities such as hypertension, weight gain, and diabetes. The same studies showed that an antipsychotic-induced reversal of these metabolic comorbidities correlated with changes in the gut microbiome composition.^[63] Finally, the association of the gut microbiome with schizophrenia could lead to alternative non-pharmaceutical approaches to treat the disorder. In particular, altering gut microbial diversity with psychobiotics can be the next promising step in schizophrenia research and clinical practice. The use of psychobiotics constitutes combining probiotics, live organisms possessing therapeutic effects, with prebiotics, food that can be processed by the probiotics in the colon, to produce metabolites that sustain the gut microbiome leading to health benefits across the gut-brain axis.^{[50,56,59,63]}

Depression is the second leading cause of disability worldwide.^[64] The role of the gut microbiome has been implicated in depressive disorders.^[65,66] Genetically speaking, changes in the gut microbiome composition could be associated with alterations in the epigenetic regulation and gene expression of receptors and mediators that are connected with depressive disorders, such as brain-derived neurotrophic factor and G protein-coupled receptors.^[65] A wide range of environmental, genetic, and lifestyle factors can contribute to variances in the gut microbiome composition, and even romantic couples with relatively high intimate kiss frequencies can show transient alterations and shares of salivary microbiota, emphasizing that contact with our cohabitants, including pets, may significantly shape the composition of our gut microbiome.^[67,68] Some studies found associations between specific alterations in the gut microbiome composition and depression. A cohort of young major depressive disorder patients was found to have an increased abundance of Neisseria spp. and Prevotella nigrescens in their salivary microbiome compared to control subjects.^[69] Another study found a relative abundance of Bacteroidetes and a reduction of Lachnospiraceae in depressed patients.^[70] Furthermore, specific bacterial genera in the gut microbiome such as Escherichia, Enterococcus, Candida, and Streptococcus, have been found to produce serotonin, a key neurotransmitter in depression.^[71] Meanwhile, antibiotics and poor diet can cause dysfunction of the gut microbiome leading to disparities in neurotransmitters that are involved in depressive disorders through the microbiome-gut-brain axis, possibly caused by either an increase in neuroinflammation or a decrease in neuroplasticity and neurogenesis, with these effects being mediated by the HPA axis or vagus nerve.^[66,70] These effects could also be mediated directly by the leakage of microbial metabolites and exogenous compounds through the disrupted gut-blood or blood-brain barriers. Innate immune responses due to digestion-resistant gliadin protein and peptides in individuals with gluten intolerance could increase the permeability of tight junctions through the increase of zonulin, which is a modulator of intercellular tight junctions and trafficking of macromolecules.^[72] Finally, clinical studies concerning the beneficial role of probiotics, prebiotics, and postbiotics in mental disorders have also encompassed depression. In particular, clinical studies have favored the potential of probiotics, to that of prebiotics or postbiotics, in reducing symptoms of depression.^[73]

Anxiety disorders are quite common among adults. Generalized anxiety disorder (GAD) is among the most common and chronic forms of anxiety, with a current prevalence of 4% to 6% of the total population.^[74] GAD is associated with daily life activities impairment and is characterized by persistent and excessive worrying.^[75]

Research has indicated that gut microbiota plays a key role in anxiety disorders through the gut-brain axis. However, in the case of anxiety, the gut microbiota affects the tryptophan-kynurenine pathway, blocking the conversion of tryptophan into serotonin, which results in serotonin depletion and the development of anxiety disorders.^[76]

The imbalance of the gut microbiota components can act as a predisposing factor to various mental disorders, including anxiety. A longitudinal pilot study performed on GAD patients indicated the relationship between GAD and decreased gut microbiota. GAD dysbiosis is characterized by the alteration of several genera of gut microbiota. The major component of the fecal microbiota, which is Bacteroides, is decreased in GAD patients in comparison with healthy individuals. In addition, the 5 SCFA-producing genera (Eubacterium rectale, Faecalibacterium, Butyricicoccus, Sutterella, and Lachnospira) were decreased in GAD patients’ guts.^[77] In addition, animal models have shown that gut microbiota regulates stress response. Sudo et al reported that the stress hormone corticosterone and adrenocorticotropic hormone in germ-free mice were elevated, due to the activation of the HPA axis.^[78]

Finally, the modulation of gut microbiota dysbiosis can have an important effect on anxiety. A recent study on mice indicated that the oral administration of Lactococcus lactis probiotic alleviated CUMS-induced anxiety and improved anxiety-like behaviors by improving gut microbiota dysbiosis through restoring the abundances of Firmicutes and Bacteroidetes. As well as reducing the serum corticosterone level, increasing serum 5-HTP levels, and restoring the central levels of serotonin.^[79]

ASD is a neurodevelopmental condition noticed in children in early life.^[80] Many genetics and environmental factors contribute to ASD pathogenesis, but the exact pathophysiology is yet understood.^[1] ASD impacts social interaction and communication. The patients also have many repetitive behaviors, eye contact avoidance, and difficulties in adaptation to changing routines.^[5,81] According to several studies, this disorder happens in males more than females, with a ratio of 4:1.^[80]

In addition to cognitive impairments, it is well-known that ASD children have various GI problems, such as gut dysfunction, constipation, diarrhea, and recurrent abdominal pain. The GI symptoms are closely correlated to ASD severity, and they might have a relation with dysbiosis in the gut microbiome.^[1,82]

Recently, researchers suggest that gut microbiota is related to ASD etiology through the microbiota-gut-brain axis. Autistic children have an alteration in their bowel microbiome composition, compared to healthy children.^[1]

For example, the GI tract of ASD patients has a considerable rise in the numbers of Desulfovibrio species, Lactobacillus species, and Clostridium perfringens.

Many studies show that gut microbiota alteration in ASD individuals may improve their behavior.^[2,83] Furthermore, the ketogenic diet (KD) may be beneficial in ASD management. The KD diet is a high-fat, appropriate-protein, low-carbohydrate diet that may be used to treat many neurological and psychiatric disorders. The mechanism behind the KD effect is still unclear, but according to animal studies, KD may improve ASD symptoms by altering the gut microbiome composition.^[83]

In this field, many promising therapies could be helpful. For instance, probiotics and FMT demonstrate a considerable effect on GI symptom treatment in ASD, they also could improve behavior problems. However, until today, much remains to be discovered about the role of the microbiota-gut-brain axis in ASD.^[84]

Table 1 summarize the relationship between gut microbiota and the recent 4 mental conditions.